Black Diamond Therapeutics, Inc.
USD1.71
+0.00 (+0.12%)
CEO
Mark A. Velleca
IPO Date
2020-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.75
Prev. Close
$1.71
Day Low
$1.70
Day High
$1.77
52W Low
$1.60
52W High
$4.94
Market Cap
$0.10B
Volume
0.57M
| 7,907 |
| $1.66 |
| 20 Mar 2026 | Behbahani Ali | director | A-Award | Acquired | 6,919 | $2.15 |
| 20 Mar 2026 | Raman Prakash | director | A-Award | Acquired | 6,105 | $2.15 |
| 23 Jan 2026 | Jones Erika | SEE REMARKS | A-Award | Acquired | 200,000 | $2.57 |
| 23 Jan 2026 | Hatzis-Schoch Brent | SEE REMARKS | A-Award | Acquired | 250,000 | $2.57 |
| 23 Jan 2026 | Buck Elizabeth | CHIEF SCIENTIFIC OFFICER | A-Award | Acquired | 250,000 | $2.57 |
| 23 Jan 2026 | Yurasov Sergey | CHIEF MEDICAL OFFICER | A-Award | Acquired | 250,000 | $2.57 |
| 23 Jan 2026 | Velleca Mark A. | director, officer: PRESIDENT & CEO | A-Award | Acquired | 600,000 | $2.57 |
| 15 Dec 2025 | Behbahani Ali | director | A-Award | Acquired | 5,208 | $2.76 |